Internal Medicine, Hematology & Oncology · Minneapolis, MN
NPI
1538370622
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
420 Delaware St SE, (Dept of Medicine)
Minneapolis, MN, 55455
Phone (612) 624-5373
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
1,027 services
Medicare patients, 2024
291
Average age 74
Drug cost, 2024
$8.6M
2,082 prescriptions
Company payments, 2025
$2,959
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gautam G Jha was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 237 times for 139 patients. In total Gautam G Jha billed 1,027 services in 36 codes, and Medicare paid $56K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 237 | 139 | $12.32 | $2,921 |
| 99214 Office E&M - Established | Office | 143 | 88 | $76.84 | $11K |
| 99215 Office E&M - Established | Office | 120 | 69 | $111.57 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 79 | 44 | $12.24 | $967 |
| 36415 Venipuncture Blood Collection | Office | 74 | 33 | $8.65 | $640 |
| 99223 Hospital E&M - Initial | Facility | 51 | 48 | $129.19 | $6,589 |
| 99215 Office E&M - Established | Facility | 49 | 32 | $108.54 | $5,318 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 36 | $87.24 | $3,926 |
| 99214 Office E&M - Established | Facility | 39 | 27 | $64.63 | $2,521 |
| 99213 Office E&M - Established | Office | 26 | 24 | $57.68 | $1,500 |
| 80053 Clinical Chemistry | Office | 22 | 17 | $10.35 | $228 |
| 85025 Blood Count | Office | 21 | 17 | $7.61 | $160 |
| 99205 Office E&M - New | Office | 14 | 14 | $132.60 | $1,856 |
By year: 2022 $153K for 7,084 services; 2023 $89K for 4,071 services; 2024 $56K for 1,027 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 74 | 33 | $8.65 | $640 |
| 80053 Clinical Chemistry | 22 | 17 | $10.35 | $228 |
| 85025 Blood Count | 21 | 17 | $7.61 | $160 |
Medicare prescription drug claims, 2024
In 2024, the drug Gautam G Jha prescribed most often to Medicare patients was Prednisone, with 355 prescriptions and refills. In total Gautam G Jha wrote 2,082 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 355 | 456 | 61 | $1,729 |
| Abiraterone Acetate Generic | 354 | 361 | 44 | $248K |
| Cabometyx Cabozantinib S-Malate | 79 | 79 | 14 | $1.9M |
| Levothyroxine Sodium Generic | 74 | 162 | 18 | $987 |
| Inlyta Axitinib | 70 | 70 | Under 11 | $1.1M |
| Dexamethasone Generic | 64 | 64 | 29 | $1,077 |
| Xarelto Rivaroxaban | 58 | 114 | 16 | $59K |
| Nubeqa Darolutamide | 56 | 56 | Under 11 | $743K |
| Xtandi Enzalutamide | 53 | 57 | Under 11 | $762K |
| Eliquis Apixaban | 53 | 99 | 14 | $57K |
| Bicalutamide Generic | 43 | 81 | 13 | $1,365 |
| Ondansetron Hcl Generic | 41 | 41 | 25 | $420 |
| Amlodipine Besylate Generic | 41 | 89 | 13 | $514 |
| Prochlorperazine Maleate Generic | 41 | 41 | 31 | $509 |
| Lenvima Lenvatinib Mesylate | 36 | 36 | Under 11 | $840K |
Brand drugs: - claims; generic drugs: 1,488 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gautam G Jha $2,959 ($2,959 in general payments such as food, travel and fees) from 7 companies. The largest payer was Eisai Inc. with $1,538.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.